ATE198147T1 - Gel mit erhöhtem sauerstoffgehalt - Google Patents

Gel mit erhöhtem sauerstoffgehalt

Info

Publication number
ATE198147T1
ATE198147T1 AT96913657T AT96913657T ATE198147T1 AT E198147 T1 ATE198147 T1 AT E198147T1 AT 96913657 T AT96913657 T AT 96913657T AT 96913657 T AT96913657 T AT 96913657T AT E198147 T1 ATE198147 T1 AT E198147T1
Authority
AT
Austria
Prior art keywords
gelatin
oxygen content
solvent
oxygen
increased oxygen
Prior art date
Application number
AT96913657T
Other languages
English (en)
Inventor
Peter Kolta
Original Assignee
Ladanyi Jozsef
Lantos Mihaly
Peter Kolta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ladanyi Jozsef, Lantos Mihaly, Peter Kolta filed Critical Ladanyi Jozsef
Application granted granted Critical
Publication of ATE198147T1 publication Critical patent/ATE198147T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Jellies, Jams, And Syrups (AREA)
AT96913657T 1995-04-26 1996-04-26 Gel mit erhöhtem sauerstoffgehalt ATE198147T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9501193A HU213450B (en) 1995-04-26 1995-04-26 Gel contains gelatin and process for producing it
PCT/HU1996/000022 WO1996033695A2 (en) 1995-04-26 1996-04-26 Gel with increased oxygen content

Publications (1)

Publication Number Publication Date
ATE198147T1 true ATE198147T1 (de) 2001-01-15

Family

ID=10986758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913657T ATE198147T1 (de) 1995-04-26 1996-04-26 Gel mit erhöhtem sauerstoffgehalt

Country Status (7)

Country Link
US (1) US6139876A (de)
EP (1) EP0822807B1 (de)
AT (1) ATE198147T1 (de)
AU (1) AU5657796A (de)
DE (1) DE69611291T2 (de)
HU (1) HU213450B (de)
WO (1) WO1996033695A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
ATE372124T1 (de) * 2001-02-01 2007-09-15 Hydron Technologies Inc Zusammensetzung und verfahren zur perkutanen superoxygenierung
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
US7648719B2 (en) * 2001-12-04 2010-01-19 Peter Kolta Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material
US8062500B2 (en) 2001-12-05 2011-11-22 Oculus Innovative Sciences, Inc. Method and apparatus for producing negative and positive oxidative reductive potential (ORP) water
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050244354A1 (en) * 2004-04-30 2005-11-03 Sam Speron Oxygenated personal care products
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
CN101072592B (zh) * 2004-10-07 2012-03-14 恩根医药有限公司 液体组合物在制备用于局部治疗开放伤和烧伤的药物中的用途
CA2602411C (en) 2005-03-23 2015-02-24 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
US9498548B2 (en) 2005-05-02 2016-11-22 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
EP1993572A2 (de) 2006-01-20 2008-11-26 Oculus Innovative Sciences, Inc. Verfahren zur behandlung oder prävention von sinusitis mit einer wasserlösung mit redoxpotenzial
US8808754B2 (en) 2006-06-29 2014-08-19 Systagenix Wound Management (Us), Inc. Methods for the treatment of wounds
DE102007028028A1 (de) 2007-06-14 2008-12-18 Beiersdorf Ag Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
US8992516B2 (en) 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
US8202272B2 (en) 2007-07-19 2012-06-19 Avedro, Inc. Eye therapy system
US8545487B2 (en) 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
US8409189B2 (en) * 2008-01-23 2013-04-02 Avedro, Inc. System and method for reshaping an eye feature
US8348935B2 (en) 2008-01-23 2013-01-08 Avedro, Inc. System and method for reshaping an eye feature
US8469952B2 (en) * 2008-01-23 2013-06-25 Avedro, Inc. System and method for positioning an eye therapy device
JP2012502763A (ja) * 2008-09-19 2012-02-02 アヴェドロ・インコーポレーテッド 眼療法システム
US8366689B2 (en) * 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
JP2012504472A (ja) * 2008-10-01 2012-02-23 アヴェドロ・インコーポレーテッド 眼治療システム
US8882757B2 (en) * 2008-11-11 2014-11-11 Avedro, Inc. Eye therapy system
US8712536B2 (en) 2009-04-02 2014-04-29 Avedro, Inc. Eye therapy system
EP2413832A1 (de) * 2009-04-02 2012-02-08 Avedro, INC. Augentherapiesystem
CA2765696C (en) 2009-06-15 2018-03-06 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
US9707126B2 (en) 2009-10-21 2017-07-18 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
US8177778B2 (en) * 2009-10-30 2012-05-15 Avedro, Inc. System and method for stabilizing corneal tissue after treatment
WO2011116306A2 (en) 2010-03-19 2011-09-22 Avedro, Inc. Systems and methods for applying and monitoring eye therapy
WO2012070888A2 (ko) * 2010-11-24 2012-05-31 (주)아모레퍼시픽 미세 버블을 함유하는 피부 외용제 조성물
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
US9020580B2 (en) 2011-06-02 2015-04-28 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
JP6644799B2 (ja) 2014-10-27 2020-02-12 アヴェドロ・インコーポレーテッドAvedro,Inc. 眼の架橋処置のためのシステム及び方法
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
US10258809B2 (en) 2015-04-24 2019-04-16 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP4483884A3 (de) 2015-05-22 2025-03-05 Avedro Inc. Systeme zur überwachung der vernetzungsaktivität für hornhautbehandlungen
KR102706856B1 (ko) 2015-07-21 2024-09-19 아베드로 인코퍼레이티드 광증감제로 눈을 치료하기 위한 시스템 및 방법
WO2019173403A1 (en) 2018-03-05 2019-09-12 Avedro, Inc. System for eye tracking during eye treatment
EP3761928A1 (de) 2018-03-08 2021-01-13 Avedro, Inc. Mikrovorrichtungen zur behandlung eines auges
CA3112932A1 (en) 2018-09-19 2020-03-26 Avedro, Inc. Systems and methods for eye tracking during eye treatment
JP7504083B2 (ja) 2018-09-19 2024-06-21 アヴェドロ・インコーポレーテッド 角膜拡張障害を治療するシステム及び方法
WO2020077015A1 (en) 2018-10-09 2020-04-16 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US12171691B2 (en) 2019-02-26 2024-12-24 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
WO2021026405A1 (en) 2019-08-06 2021-02-11 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
CA3176016A1 (en) * 2020-04-24 2021-10-28 Michael Beattie Uses of super-oxygenated water and gel
WO2022192237A1 (en) 2021-03-08 2022-09-15 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011950A (en) * 1959-05-19 1961-12-05 Colgate Palmolive Co Liquid composition containing discrete gaseous bodies
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3639575A (en) * 1968-06-19 1972-02-01 Basf Wyandotte Corp Silver ion gel compositions and method of using the same
CA2071827C (en) * 1989-12-14 1998-08-18 Brigham And Women's Hospital A treatment system for wounds and other disorders and a method for treating wounds and other skin disorders
US5152757A (en) * 1989-12-14 1992-10-06 Brigham And Women's Hospital System for diagnosis and treatment of wounds
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
DE4236607A1 (de) * 1992-10-29 1994-05-05 Lancaster Group Ag Fluorcarbonemulsion enthaltende, als Kosmetika oder Dermatika einsetzbare Zubereitungen
DE4405627A1 (de) * 1994-02-22 1995-08-24 Hoechst Ag Fluorkohlenwasserstoffe enthaltende Ölemulsionen
HU217450B (hu) * 1994-04-27 2000-01-28 Life International Products, Inc. Eljárás és berendezés oxigénnel dúsított italok előállítására

Also Published As

Publication number Publication date
HU9501193D0 (en) 1995-06-28
DE69611291D1 (de) 2001-01-25
HUT74315A (en) 1996-12-30
AU5657796A (en) 1996-11-18
WO1996033695A3 (en) 1996-11-28
US6139876A (en) 2000-10-31
WO1996033695A2 (en) 1996-10-31
EP0822807A2 (de) 1998-02-11
EP0822807B1 (de) 2000-12-20
DE69611291T2 (de) 2001-08-09
HU213450B (en) 1997-06-30

Similar Documents

Publication Publication Date Title
DE69611291D1 (de) Gel mit erhöhtem sauerstoffgehalt
KR880009639A (ko) 서방성 매트릭스 제형
ES2107022T3 (es) Composicion de polimero, composicion de un material de absorcion, su fabricacion y su empleo.
DE69736998D1 (de) Nitroimidazole enthaltende gel zusammensetzung
GR940100370A (el) Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
KR890004689A (ko) 니트로글리세린 스프레이
DK0696921T3 (da) Veterinært præparat indeholdende en protonpumpeinhibitor
DE69427908D1 (de) Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält
KR880000088A (ko) 지속적인 방출 제제
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ES2101578T3 (es) Agente analgesico y su utilizacion.
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
ES2081324T3 (es) Composicion cosmetica solida.
DE60029300D1 (de) Zusammensetzungen, die reduziertes malto-oligosaccharid als konservierungsmittel enthalten
KR870007698A (ko) α-인터페론의 안정화에 적합한 제제
BR9916304A (pt) Goma de mascar contendo agentes ativos demedicamentos
KR900015768A (ko) 고형겔 외용약 전달 시스템
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
ATE86462T1 (de) Medizinische elektrode mit hydrogelmatrix.
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
NO20013117L (no) Kosmetisk preparat av spraytype og matriks anvendt i preparatet for dermal tilforsel
GR3036822T3 (en) Eye lotion in particular for dry eye treatment
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
SU1459215A1 (ru) Состав полимерной диффузионной матрицы для трансдермального введения лекарственных веществ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties